Aminoplasmal B.Braun E10 solution for infusion Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

aminoplasmal b.braun e10 solution for infusion

b.braun melsungen ag - isoleucine, leucine, lysine (lysine hydrochloride), methionine, phenylalanine, threonine, tryptophan, valine, arginine, histidine, alanine, glycine, aspartic acid, glutamic acid, proline, serine, tyrosine, sodium acetate trihydrate, sodium hydroxide, potassium acetate, magnesium chloride hexahydrate, disodium phosphate dodecahydrate - solution for infusion - 5mg/ml+ 8.9mg/ml+ 8.56mg/ml+ 4.4mg/ml+ 4.7mg/ml+ 4.2mg/ml+ 1.6mg/ml+ 6.2mg/ml+ 11.5mg/ml+ 3mg/ml+ 10.5mg/ml+ 12mg/ml+ 5.6mg/ml+

Aminoplasmal B.Braun E10 solution for infusion Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

aminoplasmal b.braun e10 solution for infusion

b.braun melsungen ag - isoleucine, leucine, lysine (lysine hydrochloride), methionine, phenylalanine, threonine, tryptophan, valine, arginine, histidine, alanine, glycine, aspartic acid, glutamic acid, proline, serine, tyrosine, sodium acetate trihydrate, sodium hydroxide, potassium acetate, magnesium chloride hexahydrate, disodium phosphate dodecahydrate - solution for infusion - 5mg/ml+ 8.9mg/ml+ 8.56mg/ml+ 4.4mg/ml+ 4.7mg/ml+ 4.2mg/ml+ 1.6mg/ml+ 6.2mg/ml+ 11.5mg/ml+ 3mg/ml+ 10.5mg/ml+ 12mg/ml+ 5.6mg/ml+ 7.2mg/ml+ 5.5mg/ml+ 2.3mg/ml+ 0.4mg/ml+ 2.858mg/ml+ 0.36mg/ml+ 2.453mg/ml+ 0.508mg/ml+ 3.581mg/ml

Aminoplasmal B. Braun 10%E Solution for Intravenous Infusion Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

aminoplasmal b. braun 10%e solution for intravenous infusion

b.braun medical industries sdn bhd - alanine; aspartic acid; isoleucine; glutamic acid; tyrosine; arginine; leucine; histidine; lysine hydrochloride; methionine; phenylalanine; proline; serine; threonine; tryptophan; valine; sodium hydroxide; glycine; sodium acetate, trihydrate; magnesium chloride, hexahydrate; potassium acetate; disodium phosphate dodecahydrate -

AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION Singapore - English - HSA (Health Sciences Authority)

aminoplasmal b.braun 10% e solution for infusion

b. braun singapore pte ltd - alanine; arginine; aspartic acid; disodium phosphate dodecahydrate; glutamic acid; glycine; histidine; isoleucine; leucine; lysine hydrochloride; magnesium chloride hexahydrate; methionine; phenylalanine; potassium acetate; proline; serine; sodium acetate trihydrate; sodium hydroxide; threonine; tryptophan; tyrosine; valine - infusion, solution - alanine 10.50g/1000ml; arginine 11.50g/1000ml; aspartic acid 5.60g/1000ml; disodium phosphate dodecahydrate 3.581g/1000ml; glutamic acid 7.20g/1000ml; glycine 12.00g/1000ml; histidine 3.00g/1000ml; isoleucine 5.00g/1000ml; leucine 8.90g/1000ml; lysine hydrochloride 8.56g/1000ml; magnesium chloride hexahydrate 0.508g/1000ml; methionine 4.40g/1000ml; phenylalanine 4.70g/1000ml; potassium acetate 2.453g/1000ml; proline 5.50g/1000ml; serine 2.30g/1000ml; sodium acetate trihydrate 2.858g/1000ml; sodium hydroxide 0.360g/1000ml; threonine 4.20g/1000ml; tryptophan 1.60g/1000ml; tyrosine 0.40g/1000ml; valine 6.20g/1000ml

AMINOPLASMAL B. BRAUN 10% E Israel - English - Ministry of Health

aminoplasmal b. braun 10% e

lapidot medical import and marketing ltd - arginine; aspartic acid; disodium phosphate dodecahydrate; glutamine; glycine; histidine; isoleucine; l- alanine; leucine; lysine as acetate; magnesium chloride hexahydrate; methionine; phenylalanine; potassium acetate; proline; serine; sodium acetate trihydrate; threonine; tryptophan; tyrosine; valine - solution for infusion - isoleucine 5.00 g/l; leucine 8.9 g/l; methionine 4.40 g/l; phenylalanine 4.70 g/l; threonine 4.20 g/l; tryptophan 1.60 g/l; valine 6.20 g/l; arginine 11.50 g/l; histidine 3.00 g/l; glycine 12.00 g/l; l- alanine 10.50 g/l; proline 5.50 g/l; aspartic acid 5.60 g/l; glutamine 7.20 g/l; serine 2.30 g/l; tyrosine 0.40 g/l; potassium acetate 2.453 g/l; sodium acetate trihydrate 2.858 g/l; magnesium chloride hexahydrate 0.508 g/l; lysine as acetate 8.56 g/l; disodium phosphate dodecahydrate 3.581 g/l - combinations - supply of amino acids and a limited amount of electrolytes for parenteral nutrition, when oral or enteral nutrition is impossible, insufficient or contraindicated. for adults, adolescents and children over 2 years of age.

ISOLEUCINE - L Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

isoleucine - l

boehringer ingelheim animal health australia pty. ltd. - isoleucine - l - unknown - isoleucine - l amino acid-isoleucine-l active 0.0 - active constituent

TROPHAMINE- isoleucine, leucine, lysine acetate, methionine, phenylalanine, threonine, tryptophan, valine, cysteine hydrochlorid United States - English - NLM (National Library of Medicine)

trophamine- isoleucine, leucine, lysine acetate, methionine, phenylalanine, threonine, tryptophan, valine, cysteine hydrochlorid

b. braun medical inc. - isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), cysteine hydrochlo - isoleucine 0.49 g in 100 ml - trophamine® is indicated for the nutritional support of infants (including those of low birth weight) and young pediatric patients requiring tpn via either central or peripheral infusion routes. parenteral nutrition with trophamine® is indicated to prevent nitrogen and weight loss or treat negative nitrogen balance in infants and young pediatric patients where (1) the alimentary tract, by the oral, gastrostomy, or jejunostomy route, cannot or should not be used, or adequate protein intake is not feasible by these routes; (2) gastrointestinal absorption of protein is impaired; or (3) protein requirements are substantially increased as with extensive burns. dosage, route of administration, and concomitant infusion of non-protein calories are dependent on various factors, such as nutritional and metabolic status of the patient, anticipated duration of parenteral nutritional support, and vein tolerance. see warnings , precautions, pediatric use , and dosage and administration . central venous infusion should b